Clinical Trial Update: Identifying High Risk Patients With Syncope

View source ↗

Summary

A completed NHLBI-supported clinical trial update describing methods to identify high-risk patients with syncope and implications for risk stratification.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmia
• Cardiovascular Disease
• Syncope

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Arrhythmia | Status: COMPLETED